Capricor Therapeutics, Inc. (CAPR)
5.93
-0.20
(-3.26%)
USD |
NASDAQ |
Oct 23, 16:00
5.95
+0.02
(+0.34%)
After-Hours: 20:00
Capricor Therapeutics Price : 5.93 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 6.03 | 6.08 | 5.80 | 5.93 | 1.464M |
| Oct 22, 2026 | 5.83 | 6.355 | 5.80 | 6.13 | 2.755M |
| Oct 21, 2026 | 6.60 | 6.75 | 5.79 | 5.88 | 3.416M |
| Oct 20, 2026 | 6.53 | 6.834 | 6.47 | 6.61 | 2.055M |
| Oct 19, 2026 | 6.82 | 6.925 | 6.54 | 6.65 | 1.912M |
| Oct 16, 2026 | 7.21 | 7.25 | 6.68 | 6.71 | 1.955M |
| Oct 15, 2026 | 6.64 | 7.33 | 6.64 | 7.27 | 3.355M |
| Oct 14, 2026 | 6.76 | 6.885 | 6.47 | 6.59 | 2.517M |
| Oct 13, 2026 | 7.32 | 7.400 | 6.87 | 6.88 | 2.688M |
| Oct 12, 2026 | 7.79 | 7.81 | 7.445 | 7.47 | 1.460M |
| Oct 09, 2026 | 8.01 | 8.05 | 7.69 | 7.83 | 1.698M |
| Oct 08, 2026 | 7.89 | 8.17 | 7.80 | 8.01 | 2.523M |
| Oct 07, 2026 | 7.59 | 8.27 | 7.460 | 8.10 | 2.885M |
| Oct 06, 2026 | 7.75 | 7.89 | 7.46 | 7.75 | 3.133M |
| Oct 05, 2026 | 8.75 | 8.80 | 7.371 | 7.78 | 6.772M |
| Oct 02, 2026 | 9.14 | 9.24 | 8.770 | 8.95 | 2.639M |
| Oct 01, 2026 | 9.36 | 9.394 | 8.83 | 8.94 | 3.876M |
| Sep 30, 2026 | 10.03 | 10.72 | 9.40 | 9.47 | 20.57M |
| Sep 29, 2026 | 8.745 | 8.970 | 8.50 | 8.57 | 2.675M |
| Sep 28, 2026 | 8.29 | 8.840 | 8.152 | 8.71 | 2.097M |
| Sep 25, 2026 | 8.61 | 8.67 | 8.30 | 8.36 | 1.920M |
| Sep 24, 2026 | 8.60 | 8.865 | 8.27 | 8.57 | 2.402M |
| Sep 23, 2026 | 9.26 | 9.36 | 8.52 | 8.67 | 3.147M |
| Sep 22, 2026 | 9.01 | 9.48 | 8.89 | 9.34 | 2.500M |
| Sep 21, 2026 | 9.14 | 9.275 | 8.84 | 8.90 | 2.419M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ARS Pharmaceuticals, Inc. | 4.03 |
| SELLAS Life Sciences Group, Inc. | 11.54 |
| Sionna Therapeutics, Inc. | 3.60 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Cytokinetics, Inc. | 61.23 |
Price Related Metrics
| PEG Ratio | -0.0491 |
| Price to Book Value | 1.400 |
| Earnings Yield | -41.30% |
| Market Cap | 344.59M |
| PEGY Ratio | -0.0491 |